StratDeckVRTX

Vertex Pharmaceuticals Incorporated

VRTX✓
Share

Healthcare · Biotechnology · United States

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally.

Price519.51USD
1D+0.79%
Market cap132B
AnalystsBuy27
Next earnings2 Nov
Loading chart…

Trade ideas

  • Opinionated - ValueGood Opportunities—Paying up for qualityBuy27Board

Analysts

ConsensusBuy27
Mean score1.68
Mean target569.19+9.56%
Target range350.00–672.00

Value vs sector peers

#24 of 26 in HealthcarePaying up for quality20
  • Fwd P/E25.84
  • P/B6.532
  • P/E30.338
  • Rev growth+12.5%80

Not scored on Yield. The rest were reweighted to make up the difference.

Nearest in Healthcare

  1. #22JNJJohnson & JohnsonWeakest in sector24
  2. #23TMOThermo Fisher Scientific Inc.Paying up for quality23
  3. #24VRTXVertex Pharmaceuticals IncorporatedPaying up for quality20
  4. #25ISRGIntuitive Surgical, Inc.Paying up for quality10

Fundamentals

P/E30.3
Forward P/E25.8
Price / book6.50
Dividend yield—
Beta0.32
52-week range374.17–560.2578/100
ADV (USD)544M
Relative volume0.9
10d avg volume988K
Revenue growth+12.50%
EPS growth+8.00%

Performance

1D+0.79%
7D-4.87%
1M+2.72%
3M+15.33%
6M+11.46%
YTD+14.59%

In the briefing and the feed

Briefing for 11 Sept

Neither the briefing nor the research feed has named VRTX.

Catalysts

Next earnings: 2 Nov

Trade idea history

No trade idea has fired on VRTX since the ledger opened.

Get it by email

The board VRTX sits on, in one five-minute email every weekday before the New York open and on Saturdays: market strength, the biggest movers, earnings coming up and the names sitting at their 200-day EMA.